首页> 外文期刊>Seminars in Arthritis and Rheumatism >Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process
【24h】

Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process

机译:Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process

获取原文
获取原文并翻译 | 示例
           

摘要

? 2021 The Author(s)Objective: Physical function is one of the Outcome Measures in Rheumatology (OMERACT) core outcome domains for hand osteoarthritis studies. Our aim was to select appropriate instrument(s) to measure this domain, as part of the development of a core outcome measurement set. Methods: Following the OMERACT Filter 2.1 instrument selection process, the (function subscale of) the Australian/Canadian Hand Osteoarthritis Index (AUSCAN), Functional Index for Hand Osteoarthritis (FIHOA) and Michigan Hand Outcomes Questionnaire (MHQ) were assessed for domain match, feasibility, truth and discrimination. Data gathered from available literature, working group and patient surveys, and additional analyses in two hand osteoarthritis cohorts were used to inform a consensus process. Results were summarized in Summary of Measurements Properties tables and reviewed by the OMERACT technical advisory group. Results: MHQ passed the assessment of domain match and feasibility by the working group and patient research partners. For AUSCAN important limitations in feasibility were noted, but domain match was good. FIHOA did not pass the assessment and was not taken through the follow-up assessment. Based on published literature, reliability and construct/longitudinal validity of both MHQ and AUSCAN fulfilled OMERACT standards. While clinical trial discrimination and thresholds of meaning were good for AUSCAN, results for MHQ were ambiguous. Conclusion: MHQ was provisionally endorsed as OMERACT core outcome measure for the core domain physical function. While AUSCAN may have better metric properties than MHQ, it received provisional endorsement as a second measure of function due to important feasibility issues. A research agenda to merit full endorsement was set.

著录项

  • 来源
    《Seminars in Arthritis and Rheumatism》 |2021年第6期|1311-1319|共9页
  • 作者单位

    Department of Rheumatology and Department of Rheumatology Zuyderland Medical Center Leiden;

    Department of Rheumatology Leiden University Medical Center;

    University of Ottawa and Centre for Practice-Changing Research Ottawa Hospital Research InstituteMusculoskeletal Health and Outcomes Research and Department of Occupational Science andAcademic Rheumatology University of Nottingham and National Institute for Health ResearchDepartment of Rheumatology Sorbonne Université INSERM Saint-Antoine hospital AP-HPGrupo de investigación en Reumatología. Instituto de Investigación Biomédica de A Coru?a (INIBIC).Leeds Institute of Rheumatic and Musculoskeletal Medicine University of Leeds and NationalImpact Accelerator Unit School of Medicine Keele UniversityDiscipline of Medicine Adelaide and Rheumatology Department Queen Elizabeth Hospital University ofDivision of Rheumatology and Research Diakonhjemmet HospitalDepartment of Medicine Division of Rheumatology Cedars-Sinai Medical CenterInstitute of Outcomes Research Centre for Medical Statistics Informatics and Intelligent SystemsDepartment of Rheumatology Ghent University Hospital Ghent UniversityDepartments of Rheumatology and Clinical Epidemiology Leiden University Medical Center;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 免疫性疾病;
  • 关键词

    Clinical trials; Function; Hand osteoarthritis; OMERACT; Outcome measurement;

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号